Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo
Authors:
- Nahid S. WalehNWNahid S. Waleh
- Barbara K. SchneiderBSBarbara K. Schneider
- Ronald I. ClymanRCRonald I. Clyman
- Carl W. WhiteCWCarl W. White
- 1 October 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 291 (4) , L588-L595
Abstract
Development of lung microvasculature is critical for distal airway formation. Both processes are arrested in the lungs of preterm newborns with bronchopulmonary dysplasia (BPD), a chronic form of lung disease. We hypothesized that activation of hypoxia-inducible factors (HIFs) augments lung vascular development. Pulmonary angiogenic factors were assessed by quantitative real-time PCR, Western blot, and immunohistochemistry in preterm baboons (125 days + 14 days pro re nata O2 model) treated for 14 days with intravenous FG-4095, an inhibitor of prolyl hydroxylase domain-containing proteins (PHDs) that initiates HIF degradation. HIF-1α, but not HIF-2α, mRNA and protein were increased (8- and 3-fold, respectively) in FG-4095-treated baboons relative to untreated controls. Expression of PHD-1, -2, and -3 was unchanged. Of note, mRNA and/or protein for platelet-endothelial cell adhesion molecule 1 (PECAM-1) and vascular endothelial growth factor (VEGF) were increased by FG-4095. Moreover, PECAM-1-expressing capillary endothelial cells detected by immunohistochemistry were augmented in FG-4095-treated baboons to levels comparable to those in fetal age-matched controls. Alveolar septal cell expression of Ki67, a proliferative marker, and VEGF were similar in untreated controls and FG-4095-treated neonates. These results indicate that HIF stimulation by PHD inhibition enhances lung angiogenesis in the primate model of BPD.Keywords
This publication has 45 references indexed in Scilit:
- Activity of Hypoxia-inducible Factor 2α Is Regulated by Association with the NF-κB Essential ModulatorJournal of Biological Chemistry, 2005
- Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activatorsThe International Journal of Biochemistry & Cell Biology, 2005
- OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1αMolecular Cell, 2005
- Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1Blood, 2005
- Prostaglandin E 2 —Mediated Relaxation of the Ductus ArteriosusCirculation, 2004
- Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cellsThe FASEB Journal, 2004
- Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible FactorJournal of Biological Chemistry, 2003
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1αJournal of Biological Chemistry, 1997